Tresoda (trastuzumab biosimilar)
/ Incepta Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
July 25, 2025
A Study to Compare PK, Immunogenicity and Safety of Trastuzumab of Incepta Pharmaceuticals Ltd With Trastuzumab (Roche)
(clinicaltrials.gov)
- P1 | N=80 | Completed | Sponsor: Incepta Pharmaceuticals Ltd | Active, not recruiting ➔ Completed | Trial completion date: Jun 2025 ➔ Dec 2024
Trial completion • Trial completion date • Breast Cancer • Oncology • Solid Tumor
1 to 1
Of
1
Go to page
1